Stock ELV ELEVANCE HEALTH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Elevance Health, Inc.

Equities

ELV

US0367521038

Market Closed - Nyse
Other stock markets
 21:00:01 29/04/2024 BST 		5-day change 1st Jan Change
534 USD -0.61% Intraday chart for Elevance Health, Inc. +0.33% +13.24%
04-26 HCA beats first-quarter profit estimates on higher patient admissions RE
04-25 Elevance Health Insider Sold Shares Worth $10,832,155, According to a Recent SEC Filing MT

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Elevance Health Insider Sold Shares Worth $10,832,155, According to a Recent SEC Filing
MT
Mizuho Adjusts Price Target on Elevance Health to $585 From $575
MT
TD Cowen Adjusts Elevance Health's Price Target to $624 From $555
MT
UBS Adjusts Price Target on Elevance Health to $605 From $585, Maintains Buy Rating
MT
Bernstein Adjusts Price Target on Elevance Health to $665 From $629
MT
Leerink Partners Adjusts Elevance Health Price Target to $630 From $565
MT
Jefferies & Co Adjusts Elevance Health Price Target to $604 From $602
MT
Goldman Sachs Raises Elevance Health's Price Target to $600 From $578
MT
RBC Lifts Price Target on Elevance Health to $575 From $574, Cites 'Stronger Guidance,' Keeps Outperform Rating
MT
Truist Lifts Price Target on Elevance Health to $600 From $580, Notes 'Solid' Q1, 2024 Guidance Boost, Keeps Buy Rating
MT
Wells Fargo Adjusts Elevance Health's Price Target to $600 From $557, Maintains Overweight Rating
MT
Barclays Adjusts Elevance Health's Price Target to $621 From $584, Maintains Overweight Rating
MT
Cantor Fitzgerald Raises Elevance Health Price Target to $600 from $580
MT
Stephens Adjusts Elevance Health's Price Target to $615 From $580
MT
Elevance Health 1Q Revenue Rises, Membership Keeps Declining; Raises Guidance
DJ
Zacks Investment Research Adjusts Price Target on Elevance Health to $523 From $537
MT
Wells Fargo Cuts Price Target on Elevance Health to $557 From $561, Maintains Overweight Rating
MT
Barclays Starts Elevance Health With Overweight Rating, $584 Price Target
MT
Cantor Fitzgerald Adjusts Price Target on Elevance Health to $580 From $547, Maintains Overweight Rating
MT
US proposes reimbursement rate for Medicare Advantage 2025 payments
RE
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ELV Stock
  4. News Elevance Health, Inc.
  5. Analyst Reco.